Gwen Lapham, PhD, MPH
"My research focuses on primary care, currently in two areas: understanding cannabis use and integration of mental health services for adolescents."
Gwen Lapham, PhD, MPH, MSW
Assistant Investigator, Kaiser Permanente Washington Health Research Institute
Assistant Professor, Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine
Gwen.T.Lapham@kp.org
206-287-2021
Biography
Gwen Lapham, PhD, MPH, MSW, joined Kaiser Permanente Washington Health Research Institute (KPWHRI) in 2013 as an addictions health services researcher. Since then, she has capitalized on her prior social work and health services training to do impactful research on evidence-based primary care for unhealthy substance use, including alcohol, cannabis, and opioids. She has recently begun making strides in understanding cannabis use among primary care patients, including medical use and use among prenatal women.
Dr. Lapham recently completed the CATALyST K12 Washington Learning Health System Program funded by the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute. In the program, she partnered with Kaiser Permanente Washington health system leaders and with KPWHRI’s Center for Accelerating Care Transformation to address gaps in the quality of behavioral health care for children and adolescents by developing and testing an integrated approach to adolescent mental health. She expects this work to lead to new evidence for effective implementation of adolescent mental health integrated in primary care.
She is also a co-investigator of the Primary Care Opioid Use Disorders Treatment, or PROUD trial, a pragmatic implementation trial of nurse care management for treatment of opioid use disorders in primary care, as well as the Health Systems node of the National Institute on Drug Abuse Clinical Trials Network. Dr. Lapham’s research projects specific to cannabis include:
- A pilot study about the prevalence of and reasons for cannabis use among pregnant women. This study uses both cannabis screening results from the electronic health record (EHR) and qualitative interviews.
- Site principal investigator for a multisite study that examined patient-level and system-level factors associated with the Healthcare Effectiveness Data and Information Set, commonly known as HEDIS, to measure performance for initiation and engagement in treatment for patients with cannabis use disorders.
- Co-principal investigator for a study evaluating EHR documentation of medical use of cannabis. This study employs natural language processing methods to compare EHR data with data from confidential surveys about medical cannabis use.
Prior to working at KPWHRI, Dr. Lapham focused on qualitative and quantitative evaluation of preventive alcohol interventions in medical settings at the Veterans Health Administration in Seattle.
RESEARCH INTERESTS AND EXPERIENCE
-
Behavior Change
-
Addictions & Unhealthy Substance Use
-
Health Services & Economics
Implementation research; quality measurement
-
Implementation Research
Screening and brief intervention; mental health quality measurement
-
Child & Adolescent Health
-
Addictions
Prevention and treatment
Sparc trial tools
Resources for behavioral health integration
The SPARC trial successfully implemented behavioral health care into primary care. On our website, you can access tools for behavioral health integration, as well as frequently asked questions and publications.
Recent publications
Richards JE, Bobb JF, Lee AK, Lapham GT, Williams EC, Glass JE, Ludman EJ, Achtmeyer C, Caldeiro RM, Oliver M, Bradley KA. Integration of screening, assessment, and treatment for cannabis and other drug use disorders in primary care: an evaluation in three pilot sites. Drug Alcohol Depend. 2019 Aug 1;201:134-141. doi: 10.1016/j.drugalcdep.2019.04.015. Epub 2019 Jun 8. PubMed
Williams EC, McGinnis KA, Tate JP, Matson TE, Rubinsky AD, Bobb JF, Lapham GT, Edelman EJ, Catz SL, Satre DD, Bryant KJ, Marshall BDL, Kraemer KL, Bensley KM, Richards JE, Skanderson M, Justice AC, Fiellin DA, Bradley KA. HIV disease severity is sensitive to temporal changes in alcohol use: a national study of VA patients with HIV. J Acquir Immune Defic Syndr. 2019 Apr 6. doi: 10.1097/QAI.0000000000002049. [Epub ahead of print]. PubMed
Hechter RC, Horberg MA, Weisner C, Campbell CI, Contreras R, Chen LH, Yarborough BJH, Lapham GT, Haller IV, Ahmedani BK, Binswanger IA, Kline-Simon AH, Satre DD. Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis. Subst Abus. 2019;40(3):302-310. doi: 10.1080/08897077.2019.1580239. Epub 2019 Mar 25. PubMed
Bensley KM, Fortney J, Chan G, Dombrowski JC, Ornelas I, Rubinsky AD, Lapham GT, Glass JE, Williams EC. Differences in receipt of alcohol-related care across rurality among VA patients living with HIV with unhealthy alcohol use. J Rural Health. 2019 Jun;35(3):341-353. doi: 10.1111/jrh.12345. Epub 2019 Jan 31. PubMed
Campbell CI, Weisner C, Binswanger IA, Lapham GT, Ahmedani BK, Yarborough BJH, Haller IV, Altschuler A, Hechter RC, Loree AM, Kline-Simon AH. Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems. Subst Abus. 2019 Jan 24:1-7. doi: 10.1080/08897077.2018.1545729. [Epub ahead of print]. PubMed
Weisner C, Campbell CI, Altschuler A, Yarborough BJH, Lapham GT, Binswanger IA, Hechter RC, Ahmedani BK, Haller IV, Sterling SA, McCarty D, Satre DD, Kline-Simon AH. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015. Subst Abus. 2019 Jan 24:1-11. doi: 10.1080/08897077.2018.1545728. [Epub ahead of print]. PubMed
Binswanger IA, Carroll NM, Ahmedani BK, Campbell CI, Haller IV, Hechter RC, McNeely J, Yarborough BJH, Kline-Simon AH, Satre DD, Weisner C, Lapham GT. The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Subst Abus. 2019 Jan 24:1-10. doi: 10.1080/08897077.2018.1545726. [Epub ahead of print]. PubMed
Lapham GT, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller IV, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems. Subst Abus. 2019 Jan 18:1-10. doi: 10.1080/08897077.2018.1544964. [Epub ahead of print]. PubMed
Glass JE, Bobb JF, Lee AK, Richards JE, Lapham GT, Ludman E, Achtmeyer C, Caldeiro RM, Parrish R, Williams EC, Lozano P, Bradley KA. Study protocol: a cluster-randomized trial implementing Sustained Patient-centered Alcohol-related Care (SPARC trial). Implement Sci. 2018;13(1):108. doi: 10.1186/s13012-018-0795-9. PubMed
Lapham GT, Lee AK, Caldeiro RM, Glass JE, Carrell DS, Richards JE, Bradley KA. Prevalence of behavioral health conditions across frequency of cannabis use among adult primary care patients in Washington state. J Gen Intern Med. J Gen Intern Med. 2018 Nov;33(11):1833-1835. doi: 10.1007/s11606-018-4558-8. PubMed
Research
A single question helps identify patients at higher risk of cannabis use disorder
1 in 5 people who use cannabis daily at risk for moderate to severe use disorder.
Research
A better approach to prevent teen suicide deaths
New grant funds crucial work to test effectiveness of teen suicide prevention in primary care.
News
Training scientists to transform health care
Five years and 8 scholars later, KPWHRI celebrates the impact of the CATALyST training program on early-career scientists.
Research
Increasing opioid use disorder treatment in primary care
A trial led by KPWHRI researchers found that adding nurse care managers helped more people get needed treatment.
Research
Is medical use of cannabis as risky as nonmedical use?
New findings indicate medical cannabis use is associated with a lower risk of moderate to severe cannabis use disorder.
KPWHRI in the media
Frequency of cannabis use disorder in a state with legal use
Cannabis use disorder is common in one state where marijuana is legal
CNN, Aug. 29, 2023
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.